VICTORION-2 PREVENT

Objective

The VICTORION-2 PREVENT trial is a randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease.

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Cardiology Clinical Trials at 866-839-4128
or clinicaltrials@essentiahealth.org

Like most websites, we use cookies and other technologies to keep our website reliable, secure, and to better understand how our site is used. By using our site, you agree to our use of these tools. Learn more.